लोड हो रहा है...

Chimeric antigen receptors: driving immunology towards synthetic biology

The advent of second generation CARs and the CD19 paradigm have ushered a new therapeutic modality in oncology. In contrast to earlier forms of adoptive cell therapy, which were based on the isolation and expansion of naturally occurring T cells, CAR therapy is based on the design and manufacture of...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Curr Opin Immunol
मुख्य लेखक: Sadelain, Michel
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2016
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520666/
https://ncbi.nlm.nih.gov/pubmed/27372731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.06.004
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!